Helicobacter pylori isolated from patients who later failed H. pylori eradication triple therapy readily develop resistance to clarithromycin

References

1. Broutet N., Marais A., Lamouliatte H., de Mascarel A., Samoyeau R., Salamon R., Mégraud F. 2001; cagA status and eradication treatment outcome of anti- Helicobacter pylori triple therapies in patients with nonulcer dyspepsia. J Clin Microbiol 39:1319–1322 [CrossRef]
   [Google Scholar]
2. Ducóns J. A., Santolaria S., Guirao R., Ferrero M., Montoro M., Gomollón F. 1999; Impact of clarithromycin resistance on the effectiveness of a regimen for Helicobacter pylori : a prospective study of 1-week lansoprazole, amoxicillin and clarithromycin in active peptic ulcer. Aliment Pharmacol Ther 13:775–780 [CrossRef]
   [Google Scholar]
3. European Helicobacter pylori Study Group; (1997; Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut 41:8–13 [CrossRef]
   [Google Scholar]
4. Fontana C., Favaro M., Minelli S., Criscuolo A. A., Pietroiusti A., Galante A., Favalli C. 2002; New site of modification of 23S rRNA associated with clarithromycin resistance of Helicobacter pylori clinical isolates. Antimicrob Agents Chemother 46:3765–3769 [CrossRef]
   [Google Scholar]
5. Haas C. E., Nix D. E., Schentag J. J. 1990; In vitro selection of resistant Helicobacter pylori . Antimicrob Agents Chemother 34:1637–1641 [CrossRef]
   [Google Scholar]
6. Japanese Society for Helicobacter Research; (2000; Guidelines for diagnosis and treatment of Helicobacter pylori infection. Jpn J Helicobacter Res 2:2–12 (in Japanese
   [Google Scholar]
7. Kim J. J., Kim J. G., Kwon D. H. 2003; Mixed-infection of antibiotic susceptible and resistant Helicobacter pylori isolates in a single patients and underestimation of antimicrobial susceptibility testing. Helicobacter 8:202–206 [CrossRef]
   [Google Scholar]
8. Kobayashi I., Toda H., Hasegawa M., Nishida M., Fujioka T., Nasu M. 1996; Drug susceptibility of Helicobacter pylori freshly isolated from gastrointestinal mucosa of patients with peptic ulcer. Jpn J Chemother 14:719–722 (in Japanese with English summary
   [Google Scholar]
9. Kobayashi I., Saika T., Muraoka H., Inoue M., Nasu M. 2001; Relationship between clarithromycin breakpoint for Helicobacter pylori and point mutation in 23S rRNA gene. Jpn J Chemother 46:236–240 (in Japanese with English summary
   [Google Scholar]
10. Murakami K., Sato R., Okimoto T., Nasu M., Fujioka T., Kodama M., Kagawa T., Sato S., Abe H., Arita T. 2002; Eradication rates of clarithromycin-resistant Helicobacter pylori using either rabeprazole or lansoprazole plus amoxicillin and clarithromycin. Aliment Pharmacol Ther 16:1933–1938 [CrossRef]
    [Google Scholar]
11. NCCLS 2003 Performance standards for antimicrobial susceptibility testing . Thirteenth informational supplement M100-S13 Wayne, PA: NCCLS;
    [Google Scholar]
12. Suzuki J., Muraoka H., Kobayashi I., Fujita T., Mine T. 1999; Rare incidence of interspousal transmission of Helicobacter pylori in asymptomatic individuals in Japan. J Clin Microbiol 37:4174–4176
    [Google Scholar]
13. Tait-Kamradt A., Davies T., Cronan M., Jacobs M. R., Appelbaum P. C., Sutcliffe J. 2000; Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage. Antimicrob Agents Chemother 44:2118–2125 [CrossRef]
    [Google Scholar]
14. Taylor D. E., Ge Z., Purych D., Lo T., Hiratsuka K. 1997; Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations. Antimicrob Agents Chemother 41:2621–2628
    [Google Scholar]
15. van den Hulst R. W., Keller J. J., Rauws E. A., Tytgat G. N. 1996; Treatment of Helicobacter pylori infection: a review of the world literature. Helicobacter 1:6–19 [CrossRef]
    [Google Scholar]
16. Versalovic J., Osato M. S., Spakovsky K. & 7 other authors; 1997; Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance. J Antimicrob Chemother 40:283–286 [CrossRef]
    [Google Scholar]